D. Gilbert, T. Murphy, J. Jankovic
Aug 1, 2018
Citations
0
Influential Citations
45
Citations
Quality indicators
Journal
Movement Disorders
Abstract
Background: Dopamine D2 receptor antagonists used to treat Tourette syndrome may have inadequate responses or intolerable side effects. We present results of a 4‐week randomized, double‐blind, placebo‐controlled crossover study evaluating the safety, tolerability, and efficacy of the D1 receptor antagonist ecopipam in children and adolescents with Tourette syndrome.